Confocal laser endomicroscopy predicts response in patients with acute inflammatory bowel disease undergoing anti-integrin therapy with Vedolizumab.

被引:0
|
作者
Ellrichmann, Mark [1 ]
Bethge, Johannes [1 ]
Aust, Golo [1 ]
Arlt, Alexander [1 ]
Brandt, Berenice [1 ]
Zeissig, Sebastian [1 ,2 ,3 ]
Nikolaus, Susanna [1 ]
Aden, Konrad [1 ]
Schreiber, Stefan [1 ]
机构
[1] Univ Hosp Schleswig Holstein, Dept Med 1, Campus Kiel, Kiel, Germany
[2] Tech Univ Dresden, Dept Med 1, Dresden, Germany
[3] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany
关键词
D O I
10.1016/j.gie.2016.03.113
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
574
引用
收藏
页码:AB154 / AB154
页数:1
相关论文
共 50 条
  • [31] Safety and Efficacy of Anti-TNF-α and Anti-Integrin Biologics in the Treatment of Inflammatory Bowel Disease After Liver Transplantation
    Khan, Sameer
    Li, Muyi
    Al-Bawardy, Badr
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S439 - S439
  • [32] Computer-aided confocal laser endomicroscopy in inflammatory bowel disease: probing deeper into what it means
    Schneider, Yecheskel
    Buchner, Anna M.
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (03) : 637 - 638
  • [33] Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo
    Moussata, Driffa
    Goetz, Martin
    Gloeckner, Annabel
    Kerner, Marcus
    Campbell, Barry
    Hoffman, Arthur
    Biesterfeld, Stephan
    Flourie, Bernard
    Saurin, Jean-Christophe
    Galle, Peter R.
    Neurath, Markus F.
    Watson, Alastair J. M.
    Kiesslich, Ralf
    GUT, 2011, 60 (01) : 26 - 33
  • [34] A Pilot Study of Confocal Laser Endomicroscopy to Predict Barrier Dysfunction and Relapse in Pediatric Inflammatory Bowel Disease
    Shavrov, Anton
    Kharitonova, Anastasia Y.
    Davis, Elisabeth M.
    Claggett, Brian
    Morozov, Dmitriy A.
    Brown, Daniel K.
    Shavrov, Andrey A.
    Liu, Julia J.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (06): : 873 - 878
  • [35] Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy
    D'Ovidio, Valeria
    Vernia, Piero
    Gentile, Giuseppe
    Capobianchi, Angela
    Marcheggiano, Adriana
    Viscido, Angelo
    Martino, Pietro
    Caprilli, Renzo
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (02) : 180 - 183
  • [36] PREDICTORS OF ACUTE AND DELAYED VEDOLIZUMAB INFUSION REACTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Gold, Stephanie
    Cohen-Mekelburg, Shirley A.
    Schneider, Yecheskel
    Bosworth, Brian P.
    Steinlauf, Adam F.
    Scherl, Ellen
    GASTROENTEROLOGY, 2018, 154 (06) : S368 - S368
  • [37] Vitamin D Is Associated with α4β7+Immunophenotypes and Predicts Vedolizumab Therapy Failure in Patients with Inflammatory Bowel Disease
    Gubatan, John
    Rubin, Samuel J. S.
    Bai, Lawrence
    Haileselassie, Yeneneh
    Levitte, Steven
    Balabanis, Tatiana
    Patel, Akshar
    Sharma, Arpita
    Sinha, Sidhartha R.
    Habtezion, Aida
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (12): : 1980 - 1990
  • [38] Vedolizumab Drug Levels During Maintenance Therapy in Inflammatory Bowel Disease Patients
    Koduru, Pramoda
    Morrill, Amanda
    Abraham, Bincy
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S63 - S64
  • [39] Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab
    Christensen, Britt
    Rubin, David T.
    Goeppinger, Sarah
    Colman, Ruben J.
    Yarur, Andres
    Hirsch, Ayal
    Bocheneck, Ashley
    Wichmann, Alana
    Sakuraba, Atsushi
    Cohen, Russell
    Siddiqui, Dania
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S783 - S784
  • [40] Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease
    Chao, C. -Y.
    Restellini, S.
    Lemieux, C.
    Germain, P.
    Bitton, A.
    Lakatos, P. L.
    Wild, G.
    Seidman, E.
    Bessissow, T.
    Afif, W.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S367 - S368